  {"id":26439,"date":"2025-03-04T21:46:02","date_gmt":"2025-03-05T02:46:02","guid":{"rendered":"https:\/\/www.veeva.com\/cn\/?post_type=resources&#038;p=26439"},"modified":"2026-04-22T21:43:04","modified_gmt":"2026-04-23T01:43:04","slug":"top-global-biopharmas-standardize-on-veeva-china-crm-suite","status":"publish","type":"resources","link":"https:\/\/www.veeva.com\/cn\/resources\/top-global-biopharmas-standardize-on-veeva-china-crm-suite\/","title":{"rendered":"Top Global Biopharmas Standardize on 勛圖惇蹋 China CRM Suite"},"content":{"rendered":"<p class=\"text-center mb-25\"><em>6 of the top 20 biopharmas have chosen 勛圖惇蹋 for China-specific CRM<\/em><\/p>\n<p><strong class=\"introduction-highlight-text\">PLEASANTON, CA and SHANGHAI, China \u2014 March 3, 2025 \u2014 <\/strong><a href=\"\/\">勛圖惇蹋 Systems<\/a> (NYSE: VEEV) today announced that 6 of the top 20 biopharmas have now chosen 勛圖惇蹋 China CRM Suite to advance healthcare professional (HCP) engagement in China. <a href=\"https:\/\/www.veeva.com\/cn\/veeva-china-crm-suite-en\/\" rel=\"noopener\" target=\"_blank\">勛圖惇蹋 China CRM Suite<\/a> is developed in China for China leveraging 勛圖惇蹋\u2019s global development processes for compliance and quality. It includes China-specific requirements and technologies, is hosted in the country, and meets all local privacy and data export requirements.<\/p>\n<p>\u201c勛圖惇蹋 China CRM Suite is being used by more global biopharmas than any other CRM in China,\u201d said Matt Farrell, president, 勛圖惇蹋 Commercial Cloud. \u201cWe are excited that 勛圖惇蹋 China CRM Suite has become the standard for multinational corporations to deliver compliant, customer-centric HCP engagement in China.\u201d<\/p>\n<p>勛圖惇蹋 China CRM Suite is part of 勛圖惇蹋 Commercial Cloud, the global technology foundation for commercial excellence. 勛圖惇蹋 China CRM Suite includes China-specific applications to advance customer centricity including China CRM, China Events Management, Approved WeChat, China Engage, and China Campaign Manager. As a global solution, 勛圖惇蹋 China CRM Suite works seamlessly with 勛圖惇蹋 PromoMats, 勛圖惇蹋 Network, and 勛圖惇蹋 OpenData.<\/p>\n<p><strong>Additional Information<\/strong><br \/>\nFor more on 勛圖惇蹋 China CRM Suite, visit: <a href=\"http:\/\/veeva.com\/cn\/veeva-china-crm-suite-en\" rel=\"noopener\" target=\"_blank\">veeva.com\/cn\/veeva-china-crm-suite-en<\/a><\/p>\n<p><strong>About 勛圖惇蹋 Systems<\/strong><br \/>\n勛圖惇蹋 is the global leader in cloud software for the life sciences industry. Committed to innovation, product excellence, and customer success, 勛圖惇蹋 serves more than 1,000 customers, ranging from the world\u2019s largest biopharmaceutical companies to emerging biotechs. As a <a href=\"https:\/\/www.veeva.com\/pbc\/\">Public Benefit Corporation<\/a>, 勛圖惇蹋 is committed to balancing the interests of all stakeholders, including customers, employees, shareholders, and the industries it serves. For more information, visit <a href=\"\/\">veeva.com<\/a>.<\/p>\n<p><strong>Forward-looking Statements<\/strong><br \/>\nThis release contains forward-looking statements regarding 勛圖惇蹋\u2019s products and services and the expected results or benefits from use of our products and services. These statements are based on our current expectations. Actual results could differ materially from those provided in this release and we have no obligation to update such statements. There are numerous risks that have the potential to negatively impact our results, including the risks and uncertainties disclosed in our filing on Form 10- Q for the period ended October 31, 2024, which you can find <a href=\"https:\/\/www.sec.gov\/ix?doc=\/Archives\/edgar\/data\/0001393052\/000139305224000075\/veev-20241031.htm\" rel=\"noopener\" target=\"_blank\">here<\/a> (a summary of risks which may impact our business can be found on pages 36 and 37), and in our subsequent SEC filings, which you can access at <a href=\"http:\/\/sec.gov\" rel=\"noopener\" target=\"_blank\">sec.gov<\/a>.<\/p>\n<\/p>\n<p><center>###<\/center><\/p>\n<p><strong>Contact:<\/strong><\/p>\n<p>Alison Borris<br \/>\n勛圖惇蹋 Systems, U.S.<br \/>\n<a href=\"mailto:alison.borris@veeva.com\">alison.borris@veeva.com<\/a><\/p>\n<p>Lotus Cai<br \/>\n勛圖惇蹋 Systems, China<br \/>\n<a href=\"mailto:lotus.cai@veeva.com\">lotus.cai@veeva.com<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>6 of the top 20 biopharmas have chosen 勛圖惇蹋 for China-specific CRM PLEASANTON, CA and SHANGHAI, China \u2014 March 3, 2025 \u2014 勛圖惇蹋 Systems (NYSE: VEEV) today announced that 6 of the top 20 biopharmas have&#8230;<\/p>\n","protected":false},"featured_media":0,"parent":0,"menu_order":0,"template":"","meta":{"footnotes":""},"class_list":["post-26439","resources","type-resources","status-publish","hentry","resource-area-veeva-china-crm-suite","resource-area-business-suite","resource-type-news","resource-product-china-crm-suite"],"aioseo_notices":[],"_links":{"self":[{"href":"https:\/\/www.veeva.com\/cn\/wp-json\/wp\/v2\/resources\/26439"}],"collection":[{"href":"https:\/\/www.veeva.com\/cn\/wp-json\/wp\/v2\/resources"}],"about":[{"href":"https:\/\/www.veeva.com\/cn\/wp-json\/wp\/v2\/types\/resources"}],"version-history":[{"count":1,"href":"https:\/\/www.veeva.com\/cn\/wp-json\/wp\/v2\/resources\/26439\/revisions"}],"predecessor-version":[{"id":26440,"href":"https:\/\/www.veeva.com\/cn\/wp-json\/wp\/v2\/resources\/26439\/revisions\/26440"}],"wp:attachment":[{"href":"https:\/\/www.veeva.com\/cn\/wp-json\/wp\/v2\/media?parent=26439"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}